[How far should partial nephrectomy be extended for renal cell carcinoma?]
1Service d'Urologie, Hôpital Necker, 149, rue de Sèvres, 75015 Paris, France. arnaud.mejean@nck.ap-hop-paris.fr
Annales D'Urologie
|March 21, 2007
Summary
Conservative kidney cancer surgery offers high survival rates (90-100%) with low recurrence (0-3%) for tumors under 4 cm. Surgical techniques are improving, making it a viable option for more patients.
Area of Science:
- Urology
- Oncology
- Surgical Innovation
Context:
- Conservative renal surgery for kidney cancer is now widely accepted for various indications.
- Established techniques provide excellent oncological outcomes with low recurrence rates.
Purpose:
- To review the current status and evolving indications for conservative renal surgery.
- To highlight advancements in surgical techniques and their impact on outcomes.
Summary:
- Conservative surgery demonstrates 90-100% 10-year survival and 0-3% recurrence rates.
- Margin status is less critical than achieving negative margins; multifocal lesions are not contraindications.
- Tumor size and location remain key limitations, though outcomes for T1a and T1b tumors are comparable.
Impact:
- Improved surgical techniques are decreasing complication rates.
- Laparoscopic approaches are expanding, though technical challenges persist for complex cases.
- Further research is needed to confirm the safety and efficacy of extending conservative surgery to larger or parenchymal tumors.
